Correlation Between Lipocine and Paya Holdings
Can any of the company-specific risk be diversified away by investing in both Lipocine and Paya Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Paya Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Paya Holdings, you can compare the effects of market volatilities on Lipocine and Paya Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Paya Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Paya Holdings.
Diversification Opportunities for Lipocine and Paya Holdings
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Lipocine and Paya is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Paya Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paya Holdings and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Paya Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paya Holdings has no effect on the direction of Lipocine i.e., Lipocine and Paya Holdings go up and down completely randomly.
Pair Corralation between Lipocine and Paya Holdings
If you would invest 508.00 in Lipocine on October 15, 2024 and sell it today you would lose (19.00) from holding Lipocine or give up 3.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Lipocine vs. Paya Holdings
Performance |
Timeline |
Lipocine |
Paya Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lipocine and Paya Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and Paya Holdings
The main advantage of trading using opposite Lipocine and Paya Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Paya Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paya Holdings will offset losses from the drop in Paya Holdings' long position.Lipocine vs. Emergent Biosolutions | Lipocine vs. Bausch Health Companies | Lipocine vs. Neurocrine Biosciences | Lipocine vs. Teva Pharma Industries |
Paya Holdings vs. FormFactor | Paya Holdings vs. Bowhead Specialty Holdings | Paya Holdings vs. Nordic Semiconductor ASA | Paya Holdings vs. Vishay Intertechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |